Skip to main content
Top
Published in: Discover Oncology 5-6/2016

01-12-2016 | Original Paper

Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma

Authors: L. I. Velikanova, Z. R. Shafigullina, A. A. Lisitsin, N. V. Vorokhobina, K. Grigoryan, E. A. Kukhianidze, E. G. Strelnikova, N. S. Krivokhizhina, L. M. Krasnov, E. A. Fedorov, I. V. Sablin, A. L. Moskvin, E. A. Bessonova

Published in: Discover Oncology | Issue 5-6/2016

Login to get access

Abstract

Urinary steroid profiling (USP) was studied using high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) methods in 108 patients with adrenocortical adenoma (ACA) and in 31 patients with adrenocortical carcinoma (ACC). Thirteen ACC and Cushing’s syndrome (ACC-CS) patients had two types of USP as well as 18 ACC patients without hypercortisolism. These four types differed by androgen and glucocorticoid secretion of the adrenal cortex. Fifteen main ACC features were observed by GC-MS. Urinary excretion of dehydroepiandrosterone (DHEA) was increased in 67.7 % of ACC patients and tetrahydro-11-deoxycortisol (THS) in 74.2 %. By combination of the following parameters: THS >900 μg/24 h and/or DHEA >1500 μg/24 h with ratios of 3α,16,20-pregnentriol/3β,16,20-pregnentriol (3α,16,20dP3/3β,16,20dP3) less than 6.0 and 3α,17,20dP3/3β,17,20dP3 less than 9.0 and the detection of “non-classical” 5-en-pregnens, not found in ACA and healthy persons, 100 % sensitivity and specificity of ACC and ACA differential diagnosis were achieved. Features of 21-hydroxylase and 11β-hydroxylase deficiency were observed by GC-MS in 32.2 and 61.3 % of the ACC patients, respectively. Additional features for ACC-CS diagnostic were increased urinary excretion of 6β-hydroxycortisol, 18-hydroxycorticosterone, the sum (UFF + UFE) obtained by HPLC, tetrahydrocorticosterone, and the sum (THF + THE + allo-THF) obtained by GC-MS.
Literature
3.
go back to reference Reibetanz J, Kroiss M, Deutschbein T, Fenske W, Gasser M, Jurowich C, Germer CT, Allolio B, Fassnacht M (2012) German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment. Chirurg 83(6):528–535. doi:10.1007/s00104-011-2193-6 CrossRefPubMed Reibetanz J, Kroiss M, Deutschbein T, Fenske W, Gasser M, Jurowich C, Germer CT, Allolio B, Fassnacht M (2012) German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment. Chirurg 83(6):528–535. doi:10.​1007/​s00104-011-2193-6 CrossRefPubMed
4.
go back to reference Arlt W, Biehl M, Taylor AE, Hahner S, Libé R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM (2011) Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 96(12):3775–3784. doi:10.1210/jc.2011-1565 CrossRefPubMedPubMedCentral Arlt W, Biehl M, Taylor AE, Hahner S, Libé R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM (2011) Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 96(12):3775–3784. doi:10.​1210/​jc.​2011-1565 CrossRefPubMedPubMedCentral
5.
go back to reference Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429CrossRefPubMed Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429CrossRefPubMed
6.
go back to reference Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL (2005) Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab 90:871–87. doi:10.1210/jc.2004-1627 CrossRefPubMed Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL (2005) Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab 90:871–87. doi:10.​1210/​jc.​2004-1627 CrossRefPubMed
9.
go back to reference Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B, German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115(2):243–250. doi:10.1002/cncr.24030 CrossRefPubMed Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B, German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115(2):243–250. doi:10.​1002/​cncr.​24030 CrossRefPubMed
10.
go back to reference Velikanova LI, Shafigullina ZR, Vorokhobina NV, Silnitsky PA, Bessonova Ye A (2005) Diagnostic value of high performance liquid chromatography of corticosteroids in diseases of the pituitary-system. Probl Endokrinol 51(6):9–12, in Russ Velikanova LI, Shafigullina ZR, Vorokhobina NV, Silnitsky PA, Bessonova Ye A (2005) Diagnostic value of high performance liquid chromatography of corticosteroids in diseases of the pituitary-system. Probl Endokrinol 51(6):9–12, in Russ
12.
go back to reference Terzolo M, Ali A, Osella G, Reimondo G, Pia A, Peretti P, Paccotti P, Angeli A (2000) The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol 142(6):611–617CrossRefPubMed Terzolo M, Ali A, Osella G, Reimondo G, Pia A, Peretti P, Paccotti P, Angeli A (2000) The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol 142(6):611–617CrossRefPubMed
13.
go back to reference Shafigullina ZR, Velikanova LI, Vorokhobina NV, Lisitsin AA, Kukhianidze EA, Strelnikova EA, Povarov VG, Taylor NF (2015) The diagnostical importance of steroid profiles of biological fluids of patients with Cushing’s syndrome. Probl Endokrinol 61(4):4–8, (in Russ.) doi: 10.14341/probl20156144-8CrossRef Shafigullina ZR, Velikanova LI, Vorokhobina NV, Lisitsin AA, Kukhianidze EA, Strelnikova EA, Povarov VG, Taylor NF (2015) The diagnostical importance of steroid profiles of biological fluids of patients with Cushing’s syndrome. Probl Endokrinol 61(4):4–8, (in Russ.) doi: 10.14341/probl20156144-8CrossRef
14.
go back to reference Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121(3-5):496–504. doi:10.1016/j.jsbmb.2010.04.010 CrossRefPubMedPubMedCentral Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121(3-5):496–504. doi:10.​1016/​j.​jsbmb.​2010.​04.​010 CrossRefPubMedPubMedCentral
15.
go back to reference Stigliano A, Chiodini I, Giordano R, Faggiano A, Canu L, Della Casa S, Loli P, Luconi M, Mantero F, Terzolo M (2015) Management of adrenocortical carcinoma consensus statement of the Italian Society of Endocrinology (SIE). J Endocrinol Investig 39(1):103–121. doi:10.1007/s40618-015-0349-9 CrossRef Stigliano A, Chiodini I, Giordano R, Faggiano A, Canu L, Della Casa S, Loli P, Luconi M, Mantero F, Terzolo M (2015) Management of adrenocortical carcinoma consensus statement of the Italian Society of Endocrinology (SIE). J Endocrinol Investig 39(1):103–121. doi:10.​1007/​s40618-015-0349-9 CrossRef
17.
go back to reference Velikanova LI, Shafigullina ZR, Vorokhobina NV, Grigoryan K, Lisitsin AA, Obedkova EV (2015) Differential diagnostics of adrenocortical incidentalomas with different laboratory technologies. Herald of the Northwestern State Medical University named after I.I. Mechnikov 7(4):52–57, in Russ Velikanova LI, Shafigullina ZR, Vorokhobina NV, Grigoryan K, Lisitsin AA, Obedkova EV (2015) Differential diagnostics of adrenocortical incidentalomas with different laboratory technologies. Herald of the Northwestern State Medical University named after I.I. Mechnikov 7(4):52–57, in Russ
Metadata
Title
Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma
Authors
L. I. Velikanova
Z. R. Shafigullina
A. A. Lisitsin
N. V. Vorokhobina
K. Grigoryan
E. A. Kukhianidze
E. G. Strelnikova
N. S. Krivokhizhina
L. M. Krasnov
E. A. Fedorov
I. V. Sablin
A. L. Moskvin
E. A. Bessonova
Publication date
01-12-2016
Publisher
Springer US
Published in
Discover Oncology / Issue 5-6/2016
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-016-0267-0

Other articles of this Issue 5-6/2016

Discover Oncology 5-6/2016 Go to the issue